A B S T R A C T To assess potential abnormalities in collagen metabolism in systemic scleroderma, skin fibroblast lines from patients with this disease were established and compared to control cell lines derived from healthy subjects. For studies on the biosynthesis of procollagen, the cells were incubated with [14C]proline in a medium supplemented with ascorbic acid and ,8-aminopropionitrile, and the synthesis of nondialyzable [14C]hydroxyproline, in relation to DNA or cell protein, was taken as an index of procollagen formation. Five of eight scleroderma fibroblast cell lines demonstrated procollagen biosynthesis rates significantly higher than the controls, and the mean rate of procollagen synthesis by scleroderma fibroblasts was about twice that of the control cells. Control experiments demonstrated that the specific activity of the intracellular free proline was not different in scleroderma and control fibroblasts, and the mean population doubling times of the scleroderma and the control fibroblast cell lines were the same. The relative synthesis of the genetically distinct procollagens was examined by isolating type I and type III procollagens from the cell culture medium using DEAE-cellulose chromatography. The ratios of type I/III procollagens in scleroderma cell lines did not differ from the controls. The helical stability of the collagenous portion of type I and type III procollagens, estimated by the resistance of 14C-collagen to limited proteolytic digestion with pepsin under nondenaturing conditions, was the same in both A preliminary report of part of this work has been presented at
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INTRODUCTION
Systemic scleroderma (progressive systemic sclerosis) is a clinical condition of unknown etiology characterized by the diffuse accumulation of collagen in the skin, subcutaneous tissues, and a variety of internal organs (2) (3) (4) . The mechanistic details of collagen accumulation in the affected tissues have not been clarified (4) . Early evidence demonstrated an increased rate of collagen synthesis in the skin ofpatients with scleroderma (5) . This conclusion was based on the observations that the activity of prolyl hydroxylase, a key enzyme in collagen biosynthesis, was increased in skin biopsy specimens taken from patients with active disease (6, 7) . Furthermore, the incorporation of radioactive proline into cutaneous collagen and the synthesis of radioactive hydroxyproline were also increased under tissue culture conditions (8, 9) . The conclusion that collagen biosynthesis might be increased in patients with active scleroderma was further supported by the demonstration of new, labile cross-links in vivo, an observation consistent with excessive synthesis of collagen (10) . However, it has not been resolved whether each individual fibroblast is activated to produce more collagen or whether the collagen produc-tion per cell is normal but more fibroblasts are present in the diseased skin.
This question has recently been examined employing skin fibroblasts in culture but with conflicting results. Two studies have suggested that the synthesis of collagen per cell may be increased in patients with scleroderma (11) (12) (13) . In contrast, another study indicates that the synthesis of collagen by scleroderma fibroblasts is not different from that of the control cells (14) . In addition, it has also been suggested that the activity of collagenase, the enzyme initiating collagen breakdown in vivo, is decreased in scleroderma (15) . Therefore, the accumulation of collagen in the skin and other tissues could be explained by decreased degradation rather than increased deposition of collagen fibers.
In the present investigation we have employed skin fibroblasts in culture to examine certain parameters of collagen metabolism in patients with systemic scleroderma. We have assessed (a) the rate of procollagen synthesis; (b) the genetic types of the newly synthesized procollagen molecules; (c) the stability of the triple-helical conformation of the newly synthesized collagen, and (d) as incubation of parallel control cultures have indicated a variability of +18% (SD).1 At the end of the labeling period the medium was removed, and the cell layer was rinsed with 3 ml Dulbecco's modified Eagle's medium; the rinse was combined with the medium. The medium fraction was then placed in an ice bath and 1 ml of stock solution containing protease inhibitors was added to give final concentrations of 20 mM Na2EDTA, 10 mM N-ethylmaleimide, and 1 ,uM phenylmethylsulfonylfluoride. Aliquots of the media were dialyzed against running tap water for assay of total '4C-radioactivity and [14C]hydroxyproline (see below). Part of the medium was precipitated with 114 mg/ml ammonium sulfate (20% of saturation), for DEAE-cellulose chromatography or limited proteolytic digestion with pepsin (see below). The cell layer was rinsed three times with 10 ml of Hanks' balanced salt solution, and the cells were scraped with a rubber policeman into 5 ml of0.4 M NaCl, 0.1 M Tris-HCl, pH 7.5, containing 20 mM Na2EDTA, 10 mM N-ethylmaleimide, and 1 ,M phenylmethylsulfonylfluoride. The cells were sonicated at 60 Hz for 30 s. Aliquots of the cell homogenates were dialyzed against running tap water for assay of total 14C-protein and [14C]-hydroxyproline. In addition, aliquots of the cell fraction were dialyzed against 0.15 M NaCI, 0.001 M Tris-HCl, pH 7.4, for assay of DNA and total cell protein (see below).
Chromatographic procedures. For DEAE-cellulose chromatography, the 14C-proteins recovered from the medium by ammonium sulfate precipitation were dissolved in starting buffer consisting of 2 M urea and 1 mM Na2EDTA in 0.025 M Tris-HCl, pH 7.5, and dialyzed against the same buffer. The samples were then chromatographed on DEAE-cellulose using a linear gradient from 0 to 0.22 M NaCl in 0.025 M Tris-HCI buffer, pH 7.5, and containing 1 mM Na2EDTA, as described elsewhere (17, 18) .
For gel filtration on agarose, the "4C-proteins digested with pepsin (see below) were denatured by heating at 100°C for 5 min in the presence of 10 M urea, 20 mM EDTA, 10 mM Nethylmaleimide, and 1 usM phenylmethylsulfonylfluoride.
The samples were chromatographed on 6% agarose column in 1 M CaCl2, 0.05 M Tris-HCl, pH 7.5, at 22°C, as described elsewhere (19) .
Chemical and enzymatic treatments. For pepsin digestion, the "4C-proteins isolated from the culture media by ammonium sulfate precipitation were dissolved in 0.5 M acetic acid and then dialyzed against the same buffer. 100 ,ug/ml of twice crystallized pepsin (Worthington Biochemical Corp., Free- hold, N. J.) was added and the samples were incubated for 3 h at 40C. At the end of the incubation, the pH of the digests was brought to 8.5 to inactivate the pepsin, and the samples were dialyzed against 0.4 M NaCl, 0.1 M Tris-HCl, pH 7.5. The pepsin-resistant "4C-collagen molecules were then isolated by gel filtration, as described above.
Collagenase assay. To determine collagenase expression in normal and scleroderma human skin fibroblasts, the cells were washed three times in a total volume of 100 ml of Hanks' balanced salt solution. The cultures were then maintained for viously (20) , and after which enzyme activity was measured using native reconstituted ['4C]glycine-labeled collagen fibrils containing -3,000 cpm/substrate gel (21) . Immunoreactive human skin collagenase was measured by a slight modification of the double-antibody radioimmunoassay previously reported (22) . The procollagenase used as the unlabeled standard and for iodination in the radioimmunoassay was purified to homogeneity from cell culture medium as described previously (23) . This same enzyme preparation was used to produce monospecific antiserum to the enzyme (24) .
In addition to quantitating collagenase synthesis in fibroblast cultures, short-term explant cultures were established from the affected skin of two scleroderma patients for comparison with those from the skin of six control subjects. The tissue (15-30 mg wet wt) was cut into pieces -2 mm in size and cultured in Leighton tubes on a "4C-labeled native reconstituted collagen substrate (5,000 cpm/substrate gel) for 48 h at 37°C (25) . At the end of the incubation period, tissue fragments were removed and the contents of the tube were centrifuged. The amount of enzymatically degraded collagen fragments released into the supernate were determined by counting in a liquid scintillation spectrometer (25) .
Other assays. To measure the synthesis of ['4C]hydroxyproline and to determine the incorporation of '4C-radioactivity into proteins, the dialyzed medium and cell samples were hydrolyzed in 6 M HCI at 110°C for 24 h. The ['4C]-hydroxyproline in the hydrolysate was then separated from ['4C]proline on a 10 x 0.75-cm column of Beckman type W-2 polystyrene resin (Beckman Instruments, Inc., Fullerton, Calif.), eluted with 0.2 M sodium citrate buffer, pH 3.24. 1.0-ml fractions were collected, and 0.4-mi aliquots were counted in 3 ml of ACS counting solution using a Beckman LS 3155 P liquid scintillation counter (Beckman Instruments, Inc.).
Alternatively, in some experiments, the ['4C]hydroxyproline was assayed by a specific radiochemical method (26) .
To measure the specific activity of the intracellular free proline during the incubation with ['4C]proline, aliquots of the cell homogenate were precipitated with an equal volume of trichloroacetic acid, and the ['4C]proline and the total proline contents of the supernate were determined by a modification of the method described by Troll and Lindsley (27) . Because the rate of incorporation of radioactive proline into protein is affected by several factors, control experiments were performed to exclude possible sources of misinterpretation. In particular, the specific radioactivity of the intracellular free proline in all cell cultures used for the assay of procollagen biosynthesis was tested. There was no significant difference in the specific radioactivity of the intracellular free proline between scleroderma lines and the control cells (Table  III) . In further experiments, the mean population doubling times were determined in control and scleroderma fibroblast cultures. As shown in Table IV , the mean population doubling time for the scleroderma fibroblasts was not different from the control cell lines. Thus, the differences in collagen synthesis between these two groups of cells can not be accounted for by differences either in the intracellular proline pool or in the kinetics of growth.
Synthesis of type I and type III procollagens. Cultured human skin fibroblasts synthesize and secrete two major genetic types of procollagen, type I and type III (17, 30) . To estimate the relative synthesis of these procollagens, '4C-procollagen in the medium was partially purified by ammonium sulfate precipitation and type I and type III procollagen molecules were then isolated by DEAE-cellulose chromatography. The elution patterns of "4C-protein were qualitatively similar in samples obtained both from scleroderma and control fibroblasts (Fig. 1) . In all chromatograms two major peaks of radioactivity, peaks A and B, were (Fig. 1A) . The distribution of radioactivity between type I and type III procollagen was relatively constant, and the mean ratio of [14C]hydroxyproline in type I and type III procollagen in scleroderma cell cultures did not differ from the corresponding value observed in control cell lines (Table V) .
The helical stability of the genetically distinct types of collagen was also measured by subjecting the secreted 14C-procollagen, partially purified by ammonium sulfate precipitation, to limited pepsin proteolysis, and then separating the pepsin-resistant collagen polypeptides by gel filtration under denaturing conditions (Fig. 2) . The separation of type I collagen a-chains from the corresponding polypeptides of type III collagen is based on the fact that human type III collagen molecules contain interchain disulfide bonds in their triple-helical portion and they chromatograph in the y-chain position with an apparent mol wt of 285,000 (31, 32) . In contrast, the polypeptide chains of type I collagen lack such disulfide bonds and they elute from the agarose column in the a-chain position with an apparent mol wt of 94,000 daltons. Chromatography of the pepsin-resistant 14C-proteins in the cell culture media demonstrated that the ratio of type I and type III collagen molecules, which were in a stable triple-helical conformation, was the same both in scleroderma and control cell lines (Table VI) . On the basis of these experiments the synthesis of both type I and type III procollagens was increased in scleroderma Assay of entzymatically active and ilmmunologically reacting collagentase. Collagenase production was assessed in the scleroderma patients in two different ways. In initial experiments in vitro collagenase activity was measured by incubating skin explants on radioactive collagen. Collagenase activity in two scleroderma explant cultures was 136 and 157 cpm/mg wet wt, respectively, compared to 155+24 cpm/mg wet wt for six different control cultures (P = NS).
In further experiments collageniase production by scleroderma fibroblasts, using the same cell lines which were examined for the rate of procollagen biosynthesis was compared to that of control human skin fibroblast lines. First, immunoreactive collagenase protein was determined using a specific radioimmunoassay. As a group, fibroblast cultures from patients with systemic scleroderma displayed a mean value of immunoreactive enzyme protein of 121 +27% ofcontrol (mean±SE) when based on the medium protein and 113+29% of control when based on the content of cellular protein (Table VII) . Individually, however, one cell line (Expt. 4, WUS 78313) displayed only about one-third as much immunoreactive enzyme protein as the control cultures from the same experiment. Because collagenase is found in the cell culture medium in an inactive proenzyme form (20, 23) ,ul enzyme sample) to ensure complete proteolytic activation. After 10 min at 25°C, a fivefold excess ofsoybean trypsin inhibitor was added and the assay was carried out on "4C-labeled collagen substrate gels (21) . Collagenase activity is expressed as the total counts per minute "4C-collagen solubilized per nanogram immunoreactive enzyme protein in a 5-h assay at 37°C.
produce more collagen than control cells (34) . However, our preliminary studies2 employing several fibroblast lines used in this report have failed to demonstrate significant differences between control and scleroderma fibroblasts in the sensitivity to stimulation by varying concentrations of fetal calf and human serum.
In the present study, the increased biosynthesis of procollagen was characterized further by examining the distribution of newly synthesized type I and type III procollagens in the culture medium. The ratio of these two genetically distinct procollagens was unaltered in scleroderma. In normal human skin _80-85% of the collagen is type I, whereas some 10-15% of the collagen consists oftype III (19, 32) . The remaining 5% or less consists of minor forms of collagen, such as type IV, A-B, and type I-trimer collagens (19, 35, 36) . Thus in vitro, both normal human fibroblasts and cells derived from scleroderma skin synthesize type I and type III procollagens in a ratio of =5:1, a value reflecting the relative rates of in vivo procollagen synthesis. In this regard our observations do not cor- 2 Uitto et al. Unpublished observations. roborate a previous immunofluorescence study (37) suggesting that the proportions of genetically distinct collagens in the skin may vary according to the histopathologic stage of the disease, whereas the results are in agreement with a recent biochemical study (38) demonstrating no difference in the relative proportions of dermal type I and type III collagens in scleroderma.
The newly synthesized type I and type III procollagens were also examined with respect to the stability of the triple-helical portion of the molecule. As 
